FDA Investigator Priscilla M Pastrana
Priscilla M Pastrana has inspections in 5 countries as of 13 Oct 2023. Priscilla M Pastrana has collaborated with a combined 2719 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Spain,
Germany,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
France
Co-Investigator(s):
Adam R Cooke,
Aimee Cunningham, PhD,
Amy Devlin, PhD,
Andrew Byrnes, PhD,
Anissa M Cheung,
Ann Marie Montemurro,
Anna R Kwilas,
Anthony F Lorenzo,
Arduino Frankovic,
Arie C Menachem,
Ashley J Burns,
Bo Liang, PhD,
Bonita S Chester,
Brenda P King,
Brentley S Collins,
Brently S Collins,
Burnell M Henry,
Calvin B Koerner,
Carl A Perez,
CDR Cecily Jones,
CDR Jeremy L Wally, PhD,
CDR Thomas R Berry, PPh,
Christian D Lynch (CDL),
Christina Capacci Daniel, PhD,
Christopher Downey, PhD,
Claire M Minden,
Cynthia Jim, CSO,
Darcel T Bigelow,
Dawn M Braswell,
Destry M Sillivan,
Devaughn Edwards,
Dino Feigelstock (DF), PhD,
Donald C Obenhuber, PhD,
Dr. Gang Wang, PhD,
Dr. Ralph M Bernstein, PhD,
Eileen A Liu,
Ekaterina Allen,
Elias N Paz Alonzo,
Ellen Huang,
Ellen P Madigan,
Emmanuel Adu Gyamfi,
Esra Toussaint,
Gene D Arcy,
Gilbert T Salud,
Grace I Cortesini,
Gunther Bockhoudt,
Gunther Boekhoudt, PhD,
Hai Lien T Phung,
Harperd,
Haruhiko Murata,
Hector A Carrero,
Helen B Ricalde,
Hyesuk Kong,
Ibad U Khan,
J David Doleski,
Jacqueline Mdiaz Albertini,
James A Crim,
James L Kenney, DSc,
James M Simpson,
James R Evans,
James T Mccoy,
Jason F Chancey,
Jean Lhu Primmer,
Jee Chung, PhD,
Jianyang Wang,
Jie He,
John M Mcinnis,
Jose Acruz Gonzalez,
Joseph F Owens,
Joseph Kutze, PhD,
Joyce A Rockwell,
Jude C Dikes,
Julie D Bringger,
Justin A Boyd,
Justine M Corson,
Kara A Scheibner, PhD,
Kathleen R Jones, PhD,
Kevin J Matthews,
Kirsten L Vadheim, PhD,
Latorie S Jones,
Laura I Salazar, PhD,
LCDR Debra Emerson,
Lei Zhang, PhD,
Lois K Gross,
Lori S Lawless,
Marc S Neubauer,
Margaret M Annes,
Margret M Annes,
Marian E Major, PhD,
Marion Michaelis,
Martha T Olone,
Maxwell Van Tassell, PhD,
Megan A Haggerty,
Meihong Liu,
Michael J Vardon,
Michele L Forster, PhD,
Michelle M Noe,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Monique C Lo,
Nailing Zhang,
Omotunde O Osunsanmi,
Pankaj H Amin,
Patricia A Morrow,
Paul D Keller,
Paul W Keller,
Paula A Trost,
Penny H Mccarver,
Prabhu P Raju,
Qiao Y Bobo,
Randa Melhem, PhD,
Rebecca Rodriguez,
Regina Gibson Melton,
Richard H Penta,
Richard T Riggie,
Richard W Thornton,
Robert D Tollefsen,
Robert L Stevenson,
Robert W Jennings,
Rona A Leblanc,
Ronald T Nowalk,
Roy Baby,
Sean R Bryd,
Sean R Marcsisin,
Seneca D Toms,
Seth A Mailhot,
Sharmila Shrestha,
Sidney B Priesmeyer,
Simone E Pitts,
Stacey S Degarmo,
Steven A Rubin,
Steven P Donald,
Sukyoung Sohn,
Susan M Jackson,
Tamara M Casselman,
Teresita C Mercado,
Thai D Truong,
Thuy T Nguyen, LCDR,
Troy C Quander,
Victor J Gangi,
Viviana Matta,
Viviana R Ramirez,
Walter Lange,
Wanda E Pagan, PhD,
Wayne E Seifert,
Wei Wang, PhD,
Xianghong Jing (Emily), PhD,
Xiao Wang,
Yanming An, PhD,
Zhao Wang, PhD,
Zhihao Qiu (Peter), PhD
Priscilla M Pastrana's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2012 | FDA 483 | Rhein Biotech GmbH, A wholly owned sub. of Dynavax Tech. - Form 483, 2012-08-23 |
June, 2022 | FDA 483 | Seqirus Inc - Form 483, 2022-06-09 |
June, 2022 | FDA 483 Response | Seqirus Inc - Form 483R, 2022-06-24 |
June, 2020 | FDA 483 | Catalent Maryland, Inc. - Form 483, 2020-06-19 |
June, 2022 | EIR | Seqirus Inc - EIR, 2022-06-09 |
April, 2011 | FDA 483 | Dendreon Pharmaceuticals LLC - Form 483, 2011-04-08 |
December, 2011 | FDA 483 | Lonza Walkersville, Inc. - Form 483, 2011-12-02 |
April, 2018 | FDA 483 | Siwa Biotech Corp. - Form 483, 2018-04-27 |
December, 2011 | EIR | Lonza Walkersville, Inc. - EIR, 2011-12-02 |
June, 2020 | FDA 483 Response | Catalent Maryland, Inc. - Form 483R, 2020-07-13 |
September, 2023 | FDA 483 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2023-09-19 |
December, 2023 | FDA 483 | Brammer Bio MA, LLC - Form 483, 2023-12-19 |
November, 2022 | FDA 483 | Krystal Biotech, Inc. - Form 483, 2022-11-16 |
December, 2023 | FDA 483 | Avioq, Inc. - Form 483, 2023-12-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more